tradingkey.logo
tradingkey.logo

Alterity Therapeutics Presents Ath434-201 Phase 2 Clinical Trial Results At European Msa Symposium

ReutersApr 28, 2025 12:11 PM

- Alterity Therapeutics Ltd ATH.AX:

  • ALTERITY THERAPEUTICS PRESENTS ATH434-201 PHASE 2 CLINICAL TRIAL RESULTS AT EUROPEAN MSA SYMPOSIUM

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

KeyAI